Gpr18 agonist dampens inflammation, enhances myogenesis, and restores muscle function in models of Duchenne muscular dystrophy
Junio Dort(Centre Hospitalier Universitaire Sainte-Justine), Nicolas A. Dumont(Centre Hospitalier Universitaire Sainte-Justine)
Cited by 17
Related Papers
Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy
|Nature Communications|2021|75
Bioactive lipid mediator class switching regulates myogenic cell progression and muscle regeneration
|Nature Communications|2025|11